Literature DB >> 8902256

Neuropeptide changes in a case of chronic paroxysmal hemicrania--evidence for trigemino-parasympathetic activation.

P J Goadsby1, L Edvinsson.   

Abstract

Chronic paroxysmal hemicrania (CPH) is a rare headache syndrome of short-lasting attacks of pain, characterized clinically by trigemino-parasympathetic activation. The features of the headache are severe attacks of pain that generally last no more than minutes in association with autonomic activation, such as lacrimation or rhinorrhea. We report a patient fulfilling International Headache Society guidelines for the diagnosis of CPH in whom levels of calcitonin gene-related peptide (CGRP) and vasoactive intestinal polypeptide (VIP) were elevated in the cranial circulation during attacks. Moreover, successful treatment of the problem with indomethacin leads to normalization of the levels of both CGRP and VIP. Given that similar neuropeptide changes are seen in cluster headache the data suggest a shared underlying pathophysiology between CPH and cluster headache.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902256     DOI: 10.1046/j.1468-2982.1996.1606448.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  22 in total

Review 1.  Diencephalic and brainstem mechanisms in migraine.

Authors:  Simon Akerman; Philip R Holland; Peter J Goadsby
Journal:  Nat Rev Neurosci       Date:  2011-09-20       Impact factor: 34.870

Review 2.  Calcitonin gene-related peptide antagonists as treatments of migraine and other primary headaches.

Authors:  Peter J Goadsby
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Trigeminal autonomic cephalgias.

Authors:  Rafael Benoliel
Journal:  Br J Pain       Date:  2012-08

Review 4.  Effective management of ice pick pains, SUNCT, and episodic and chronic paroxysmal hemicrania.

Authors:  L C Newman
Journal:  Curr Pain Headache Rep       Date:  2001-06

Review 5.  The pathophysiology of the trigeminal autonomic cephalalgias, with clinical implications.

Authors:  Mads C J Barloese
Journal:  Clin Auton Res       Date:  2017-09-23       Impact factor: 4.435

6.  Trigeminal TRPs and the scent of pain.

Authors:  Sven-Eric Jordt
Journal:  Pain       Date:  2010-11-30       Impact factor: 6.961

Review 7.  [Paroxysmal hemicrania and SUNCT].

Authors:  H Göbel; C Göbel; A Heinze
Journal:  Schmerz       Date:  2011-12       Impact factor: 1.107

Review 8.  Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implications.

Authors:  L Edvinsson
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 9.  [What is needed to develop a headache? Anatomical and pathophysiological implications].

Authors:  U Reuter; A May
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

Review 10.  Indomethacin-responsive headache syndromes.

Authors:  David W Dodick
Journal:  Curr Pain Headache Rep       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.